Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1982 1
1987 1
1989 1
1990 1
1991 2
1992 1
1993 3
1994 2
1996 1
2001 3
2002 6
2003 3
2004 5
2005 6
2006 1
2007 4
2008 5
2009 14
2010 10
2011 12
2012 14
2013 17
2014 19
2015 19
2016 7
2017 22
2018 23
2019 26
2020 18
2021 26
2022 28
2023 36
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

308 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.
Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, Kolkhof P, Nowack C, Schloemer P, Joseph A, Filippatos G; FIDELIO-DKD Investigators. Bakris GL, et al. N Engl J Med. 2020 Dec 3;383(23):2219-2229. doi: 10.1056/NEJMoa2025845. Epub 2020 Oct 23. N Engl J Med. 2020. PMID: 33264825 Free article. Clinical Trial.
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy.
Barratt J, Lafayette R, Kristensen J, Stone A, Cattran D, Floege J, Tesar V, Trimarchi H, Zhang H, Eren N, Paliege A, Rovin BH; NefIgArd Trial Investigators. Barratt J, et al. Kidney Int. 2023 Feb;103(2):391-402. doi: 10.1016/j.kint.2022.09.017. Epub 2022 Oct 19. Kidney Int. 2023. PMID: 36270561 Free article. Clinical Trial.
To verify these findings, the phase 3 NefigArd trial tested the efficacy and safety of nine months of treatment with Nefecon (16 mg/d) versus placebo in adult patients with primary IgAN at risk of progressing to kidney failure (ClinicalTrials.gov: NCT03643965). ...
To verify these findings, the phase 3 NefigArd trial tested the efficacy and safety of nine months of treatment with Nefecon (16 mg/d …
Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis.
Singh AK, Carroll K, Perkovic V, Solomon S, Jha V, Johansen KL, Lopes RD, Macdougall IC, Obrador GT, Waikar SS, Wanner C, Wheeler DC, Więcek A, Blackorby A, Cizman B, Cobitz AR, Davies R, Dole J, Kler L, Meadowcroft AM, Zhu X, McMurray JJV; ASCEND-D Study Group. Singh AK, et al. N Engl J Med. 2021 Dec 16;385(25):2325-2335. doi: 10.1056/NEJMoa2113379. Epub 2021 Nov 5. N Engl J Med. 2021. PMID: 34739194 Clinical Trial.
CONCLUSIONS: Among patients with CKD undergoing dialysis, daprodustat was noninferior to ESAs regarding the change in the hemoglobin level from baseline and cardiovascular outcomes. (Funded by GlaxoSmithKline; ASCEND-D ClinicalTrials.gov number, NCT02879305.)....
CONCLUSIONS: Among patients with CKD undergoing dialysis, daprodustat was noninferior to ESAs regarding the change in the hemoglobin level f …
Nephrology: achieving sustainability.
Blankestijn PJ, Bruchfeld A, Cozzolino M, Fliser D, Fouque D, Gansevoort R, Goumenos D, Massy ZA, Rychlık I, Soler MJ, Stevens K, Zoccali C. Blankestijn PJ, et al. Nephrol Dial Transplant. 2020 Dec 4;35(12):2030-2033. doi: 10.1093/ndt/gfaa193. Nephrol Dial Transplant. 2020. PMID: 32901289 No abstract available.
Nutritional vitamin D in CKD: Should we measure? Should we treat?
Capelli I, Cianciolo G, Gasperoni L, Galassi A, Ciceri P, Cozzolino M. Capelli I, et al. Clin Chim Acta. 2020 Feb;501:186-197. doi: 10.1016/j.cca.2019.11.010. Epub 2019 Nov 23. Clin Chim Acta. 2020. PMID: 31770508 Review.
Vitamin Ddeficiency is frequently present in patients affected by chronic kidney disease (CKD). Experimental studies demonstrated that Vitamin D may play a role in the pathophysiology of diseases beyond mineral bone disorders in CKD (CKD-MBD). ...In conclusion, treatment o …
Vitamin Ddeficiency is frequently present in patients affected by chronic kidney disease (CKD). Experimental studies demonstrated that Vitam …
Reduction of Cardiac Fibrosis by Interference With YAP-Dependent Transactivation.
Garoffolo G, Casaburo M, Amadeo F, Salvi M, Bernava G, Piacentini L, Chimenti I, Zaccagnini G, Milcovich G, Zuccolo E, Agrifoglio M, Ragazzini S, Baasansuren O, Cozzolino C, Chiesa M, Ferrari S, Carbonaro D, Santoro R, Manzoni M, Casalis L, Raucci A, Molinari F, Menicanti L, Pagano F, Ohashi T, Martelli F, Massai D, Colombo GI, Messina E, Morbiducci U, Pesce M. Garoffolo G, et al. Circ Res. 2022 Jul 22;131(3):239-257. doi: 10.1161/CIRCRESAHA.121.319373. Epub 2022 Jun 30. Circ Res. 2022. PMID: 35770662 Free article.
Vitamin D in Kidney Transplant Recipients: Mechanisms and Therapy.
Cianciolo G, Galassi A, Capelli I, Angelini ML, La Manna G, Cozzolino M. Cianciolo G, et al. Am J Nephrol. 2016;43(6):397-407. doi: 10.1159/000446863. Epub 2016 May 28. Am J Nephrol. 2016. PMID: 27229347 Free article. Review.
This review analyzes the pathophysiology of vitamin D derangement in KTRs and its fall out on patient and graft outcome, highlighting the roles of both nutritional and active vitamin D compounds to treat PTBD, cardiovascular disease (CVD) and graft dysfunction. ...V …
This review analyzes the pathophysiology of vitamin D derangement in KTRs and its fall out on patient and graft outcome, highlighting …
Vitamin D: physiology and pathophysiology.
Gallieni M, Cozzolino M, Fallabrino G, Pasho S, Olivi L, Brancaccio D. Gallieni M, et al. Int J Artif Organs. 2009 Feb;32(2):87-94. doi: 10.1177/039139880903200205. Int J Artif Organs. 2009. PMID: 19363780 Review.
Although vitamin D was initially considered a nutrient, it has been recognized that the molecules derived from vitamin D metabolism are best considered as a complex endocrine system. In this review article we summarize the basic concepts regarding vitamin D m …
Although vitamin D was initially considered a nutrient, it has been recognized that the molecules derived from vitamin D metab …
Which vitamin D in CKD-MBD? The time of burning questions.
Galassi A, Bellasi A, Auricchio S, Papagni S, Cozzolino M. Galassi A, et al. Biomed Res Int. 2013;2013:864012. doi: 10.1155/2013/864012. Epub 2013 Aug 7. Biomed Res Int. 2013. PMID: 23991423 Free PMC article. Review.
Vitamin D is a common treatment against secondary hyperparathyroidism in renal patients. However, the rationale for the prescription of vitamin D sterols in chronic kidney disease (CKD) is rapidly increasing due to the coexistence of growing expectancies close to un …
Vitamin D is a common treatment against secondary hyperparathyroidism in renal patients. However, the rationale for the prescription …
308 results